Skip to content

A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin® Once liquid gel compared with Lyclear 1% permethrin crème rinse in the treatment of head lice - Hedrin Once versus Lyclear against head lice

A randomised, controlled, assessor-blind, clinical trial to demonstrate superiority of Hedrin® Once liquid gel compared with Lyclear 1% permethrin crème rinse in the treatment of head lice - Hedrin Once versus Lyclear against head lice

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-000257-23-GB
Enrollment
84
Registered
2011-05-03
Start date
2011-06-14
Completion date
Unknown
Last updated
2012-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head louse infestation (pediculosis capitis) MedDRA version: 13.1 Level: LLT Classification code 10034214 Term: Pediculus capitis (head louse) System Organ Class: 10021881 - Infections and infestations

Interventions

Trade Name: Lyclear creme rinse Product Name: Lyclear creme rinse Pharmaceutical Form: Cream INN or Proposed INN: permethrin CAS Number: 52645-53-1 Other descriptive name: 3-Phenoxybenzyl (1RS)-cis,tr

Sponsors

Thornton & Ross Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Children and adults aged 6 months and over of both sexes with no upper age limit. 2. People who upon examination, are confirmed to have live head lice. 3. People who give written informed consent or, if the participant is under 16 years of age, whose parent/guardian gives written informed consent to participate in the study. 4. People who will be available for follow up visits by study team members over the 14 days following first treatment. Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: 1. People with a known sensitivity to any of the ingredients in Hedrin Once liquid gel or Lyclear 1% permethin creme rinse. 2. People with a bacterial infection of the scalp (e.g. impetigo) or who have an active long term scalp condition (e.g. psoriasis of the scalp). 3. People who have been treated with other head lice products within the previous two weeks. 4. People who have been treated with the antibiotics CoTrimoxazole or Trimethoprim within the previous four weeks, or who are currently taking such a course. 5. Pregnant or nursing mothers. 6. People who have participated in another clinical study within 1 month before entry to this study. 7. People who have already participated in this clinical study.

Design outcomes

Primary

MeasureTime frame
Main Objective: To confirm the efficacy of Hedrin Once liquid gel using a single application of 15 minutes duration;Secondary Objective: To compare efficacy of Hedrin Once liquid gel with that of Lyclear creme rinse for elimination of infestation with head lice.;Primary end point(s): The primary outcome measure for each of the treatments is cure (or exceptionally cure followed by reinfestation from a contact, as defined by algorithm), indicated by no evidence of active head louse infestation following treatment (in the case of Lyclear creme rinse following the second application of treatment)

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Mar 23, 2026